{"meta":{"query_hash":"7434c6d62b26","filters":{"venue":"Therapeutic Advances in Urology"},"cohort_total":34,"direct_labels_cover":0,"predictions_cover":34,"exported":34,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/7434c6d62b26","api":"https://metacan.xera.ac/api/v1/cohort?venue=Therapeutic+Advances+in+Urology"},"results":[{"id":"W2000346326","doi":"10.1177/1756287211433187","title":"Variations in the quality of care at radical prostatectomy","year":2012,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Intensive care medicine; Quality of life (healthcare); Quality (philosophy); Disease; Randomized controlled trial; Prostate cancer; Nursing; Surgery; Internal medicine; Cancer","score_opus":0.025921118712789282,"score_gpt":0.36652715160105437,"score_spread":0.3406060328882651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000346326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9298339,0.05006133,0.0029430108,0.0033527769,0.0002544048,0.00009169951,0.0028938018,0.000055971614,0.010513031],"genre_scores_gemma":[0.99594754,0.0026505042,0.00039098592,0.00018564012,0.00005334497,0.0000185778,0.00054067344,0.0000061614514,0.00020673718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99462163,0.002045316,0.0007656112,0.0006659117,0.0015582775,0.00034328006],"domain_scores_gemma":[0.98683363,0.0043565077,0.0058572786,0.000647689,0.0014287349,0.00087618164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003214763,0.00007308787,0.000389202,0.0010029896,0.00026897425,0.00085896323,0.00048928126,0.0003363698,0.0016725878],"category_scores_gemma":[0.022126568,0.00008211501,0.00061487325,0.002593497,0.00050698133,0.00046412126,0.0008139675,0.00054200774,0.00016138861],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016377334,0.00003628406,0.9192997,0.0004199264,0.0007246418,0.00007921872,0.00048705415,0.00054718787,0.00031241312,0.0010192754,0.0012235079,0.07568693],"study_design_scores_gemma":[0.0000030523593,0.000037536553,0.99829704,0.000049324262,0.000026731008,0.000064908825,0.00011673966,0.00007094083,0.000037149053,0.00029428306,0.0009957158,0.00000660312],"about_ca_topic_score_codex":0.0063497974,"about_ca_topic_score_gemma":0.007360308,"teacher_disagreement_score":0.0063497974,"about_ca_system_score_codex":0.0013596502,"about_ca_system_score_gemma":0.0010713434,"threshold_uncertainty_score":0.01700151},"labels":[],"label_agreement":null},{"id":"W2015323328","doi":"10.1177/1756287209341306","title":"Update on ureteral stent technology","year":2009,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Ureteral procedures and complications","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Stent; Ureter; Ketorolac; Surgery; Urology; Pharmacology","score_opus":0.013581368960595962,"score_gpt":0.3143437872945598,"score_spread":0.30076241833396383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015323328","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019870831,0.93827635,0.0035963207,0.014010378,0.015143168,0.000031326872,0.0002609449,0.00023080505,0.026463607],"genre_scores_gemma":[0.007812843,0.9370353,0.0074411617,0.01097852,0.016519303,0.000043571446,0.0005655574,0.000060007944,0.01954373],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99918777,0.00013308463,0.0001532553,0.00007796879,0.00039485877,0.00005306802],"domain_scores_gemma":[0.995911,0.0015571312,0.00028322713,0.00013253817,0.0018093451,0.00030672146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017150057,0.00063859165,0.0008972325,0.0027214382,0.00034811738,0.0016333759,0.0010557882,0.0027082092,0.010225759],"category_scores_gemma":[0.004132384,0.0003295307,0.00061359676,0.0018173557,0.00041161707,0.0024887363,0.00053481973,0.0023644385,0.0058761504],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011528399,0.00010458747,0.0008596701,0.0029867098,0.00004953586,0.0010365526,0.000058950085,0.00035843972,0.0016421288,0.0029067374,0.13840559,0.85147583],"study_design_scores_gemma":[0.000010131207,0.00008498229,0.000567292,0.00084088556,0.000045480712,0.00293357,0.000025885083,0.00011925048,0.0007365045,0.00060672016,0.9940158,0.0000134994725],"about_ca_topic_score_codex":0.0010867743,"about_ca_topic_score_gemma":0.0023946487,"teacher_disagreement_score":0.010225759,"about_ca_system_score_codex":0.0006869897,"about_ca_system_score_gemma":0.0012297021,"threshold_uncertainty_score":0.034208596},"labels":[],"label_agreement":null},{"id":"W2031247135","doi":"10.1177/1756287215576647","title":"The role of radiation therapy in the treatment of metastatic castrate-resistant prostate cancer","year":2015,"lang":"en","type":"review","venue":"Therapeutic Advances in Urology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Interior Health; BC Cancer Agency","funders":"","keywords":"Medicine; Prostate cancer; Radiation therapy; Spinal cord compression; Oncology; Disease; Prostate; Cancer; Internal medicine; Spinal cord","score_opus":0.058592698952738,"score_gpt":0.40236667933264136,"score_spread":0.34377398037990337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031247135","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000078383855,0.9992471,0.000042832515,0.00011368644,0.000056783483,0.0000015450019,0.0000048964594,0.0000021171168,0.00045272414],"genre_scores_gemma":[0.00047081805,0.9991598,0.00006695526,0.00008060934,0.00007745761,0.0000014328004,0.000007177153,5.87137e-7,0.00013516733],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997961,0.00004387289,0.00003273682,0.000030794396,0.00008161824,0.000014847436],"domain_scores_gemma":[0.9996625,0.00018987959,0.000052695985,0.000008506955,0.00006475767,0.000021663338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005619593,0.0004858706,0.0009207232,0.0019794481,0.00025938542,0.00070868136,0.00065596664,0.00070433377,0.0022736876],"category_scores_gemma":[0.00068767124,0.00018226856,0.00051433314,0.0018240745,0.00050511945,0.00087457773,0.0005272557,0.0015283899,0.0009479712],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047902213,0.000053998046,0.0002189657,0.017379627,0.00009323577,0.00023271418,0.00007257948,0.00033836908,0.0011228714,0.0024849586,0.014470086,0.96348464],"study_design_scores_gemma":[0.000019302326,0.00015698002,0.0015926935,0.007185493,0.00017071298,0.003623839,0.00009669977,0.000111873596,0.00048198676,0.0016762502,0.9848588,0.000025313193],"about_ca_topic_score_codex":0.0011707023,"about_ca_topic_score_gemma":0.0024906513,"teacher_disagreement_score":0.0022736876,"about_ca_system_score_codex":0.00043843137,"about_ca_system_score_gemma":0.00075627427,"threshold_uncertainty_score":0.0076062083},"labels":[],"label_agreement":null},{"id":"W2046352265","doi":"10.1177/1756287212445179","title":"Sacral neuromodulation and refractory overactive bladder: an emerging tool for an old problem","year":2012,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Overactive bladder; Sacral nerve stimulation; Refractory (planetary science); Neuromodulation; Botulinum toxin; Urology; Safety profile; Intensive care medicine; Surgery; Adverse effect; Internal medicine","score_opus":0.047715799311919736,"score_gpt":0.39036097370943174,"score_spread":0.342645174397512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046352265","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014806502,0.9899974,0.0005169796,0.005742172,0.00066668313,0.000004571361,0.000012613678,0.00001733374,0.0015616026],"genre_scores_gemma":[0.015197227,0.9741474,0.0013518524,0.004067751,0.0033967437,0.00000827003,0.000027971044,0.000009216846,0.0017936183],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996357,0.00009490733,0.00005355835,0.000057814035,0.00012429636,0.00003380625],"domain_scores_gemma":[0.9991561,0.00044651813,0.00016227787,0.000025356294,0.00013726411,0.00007259987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073073345,0.000546409,0.0014850328,0.0019181535,0.0005163296,0.0018255562,0.00061445904,0.001765661,0.003447213],"category_scores_gemma":[0.0012891159,0.00016714692,0.0003822223,0.0015795535,0.0012114154,0.0028728761,0.0008257409,0.0014251806,0.0011554335],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014668024,0.00012871879,0.003726785,0.00785657,0.00012530632,0.005876852,0.0003514651,0.00012470095,0.002663628,0.005855317,0.026641397,0.94650257],"study_design_scores_gemma":[0.000060721723,0.00075817946,0.015505525,0.010899464,0.00048638406,0.12624885,0.0027444768,0.00061073055,0.0019523334,0.01270985,0.8278839,0.0001395458],"about_ca_topic_score_codex":0.00052147696,"about_ca_topic_score_gemma":0.0012513817,"teacher_disagreement_score":0.003447213,"about_ca_system_score_codex":0.00045264605,"about_ca_system_score_gemma":0.001068293,"threshold_uncertainty_score":0.011532068},"labels":[],"label_agreement":null},{"id":"W2048624682","doi":"10.1177/1756287209103921","title":"Review: Prostate capsule sparing radical cystectomy: oncologic safety and clinical outcome","year":2009,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Cystectomy; Medicine; Cystoprostatectomy; Urology; Prostate; Prostate cancer; Prostatectomy; Bladder cancer; Urinary diversion; Cancer; Internal medicine","score_opus":0.03919003386742824,"score_gpt":0.4041269195165172,"score_spread":0.36493688564908894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048624682","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010636264,0.99600995,0.00005264082,0.0007105847,0.0005943488,0.000020336733,0.00013259747,0.0000073967585,0.0014085029],"genre_scores_gemma":[0.013511045,0.98273253,0.0001738346,0.001074865,0.0013251852,0.000041217652,0.00030723936,0.000004837053,0.000829237],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9993943,0.00016217436,0.00014816389,0.000052881885,0.00021144949,0.00003100289],"domain_scores_gemma":[0.9971155,0.0015728365,0.00049381505,0.00003530497,0.00068077975,0.00010183625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008948083,0.00058424607,0.0023020338,0.001473188,0.00023434285,0.0008965416,0.0008916164,0.0011770233,0.0046620793],"category_scores_gemma":[0.005031903,0.00018061652,0.00048350048,0.0025146417,0.00035927634,0.00066361006,0.00026406054,0.0004542189,0.0016841447],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080358743,0.00009864052,0.0048291385,0.076113775,0.0010247602,0.0015639791,0.00007966722,0.00042047087,0.00065473525,0.0004658118,0.18683818,0.72710717],"study_design_scores_gemma":[0.0007710154,0.0017681703,0.051241156,0.08161716,0.005486851,0.03285753,0.0003827901,0.00036303187,0.0010634478,0.0017370279,0.8226001,0.00011169139],"about_ca_topic_score_codex":0.0013404462,"about_ca_topic_score_gemma":0.0015942028,"teacher_disagreement_score":0.0046620793,"about_ca_system_score_codex":0.0005449301,"about_ca_system_score_gemma":0.0016764195,"threshold_uncertainty_score":0.015596151},"labels":[],"label_agreement":null},{"id":"W2081791238","doi":"10.1177/1756287215576626","title":"Tadalafil therapy for erectile dysfunction following prostatectomy","year":2015,"lang":"en","type":"review","venue":"Therapeutic Advances in Urology","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Tadalafil; Medicine; Erectile dysfunction; Prostatectomy; cGMP-specific phosphodiesterase type 5; Urology; Erectile function; Rehabilitation; Internal medicine; Prostate; Physical therapy","score_opus":0.1071181945036383,"score_gpt":0.42785160847479503,"score_spread":0.32073341397115673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081791238","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025180084,0.9990753,0.00002747218,0.00010162135,0.000068012334,0.0000039844804,0.000018285764,0.0000024992305,0.00045113213],"genre_scores_gemma":[0.0019698762,0.9975031,0.000072380906,0.0001236193,0.00010307612,0.000004696838,0.00002963447,6.2255725e-7,0.00019301835],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997898,0.000049318838,0.000052375508,0.000025438736,0.000070625494,0.000012448391],"domain_scores_gemma":[0.99972767,0.00015864977,0.00005496758,0.0000059443955,0.00004121839,0.000011525677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048790383,0.0003316727,0.00086008816,0.0015896275,0.00023497042,0.0006083594,0.0005020416,0.00050616096,0.0038758474],"category_scores_gemma":[0.00083221146,0.00010915298,0.00063600723,0.0016746727,0.00020625052,0.0005100926,0.00034164306,0.0006464001,0.0007070471],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014813378,0.000091432805,0.0006336096,0.05557537,0.0003584631,0.0003843159,0.000107850334,0.00010412202,0.0008828277,0.00083606364,0.014111631,0.92676616],"study_design_scores_gemma":[0.00011288404,0.00049004576,0.009995695,0.04526369,0.0019057886,0.006619156,0.00030030354,0.00015679514,0.0010795123,0.00136683,0.93267256,0.000036671125],"about_ca_topic_score_codex":0.0008339019,"about_ca_topic_score_gemma":0.0024737043,"teacher_disagreement_score":0.0038758474,"about_ca_system_score_codex":0.0002382033,"about_ca_system_score_gemma":0.0007859819,"threshold_uncertainty_score":0.012966037},"labels":[],"label_agreement":null},{"id":"W2092515164","doi":"10.1177/1756287213490054","title":"Evidence for the efficacy of enzalutamide in postchemotherapy metastatic castrate-resistant prostate cancer","year":2013,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Enzalutamide; Medicine; Docetaxel; Cabazitaxel; Prostate cancer; Clinical endpoint; Oncology; Internal medicine; Androgen receptor; Adverse effect; Placebo; Randomized controlled trial; Cancer; Androgen deprivation therapy; Pathology","score_opus":0.08138430740976331,"score_gpt":0.4173034587040115,"score_spread":0.33591915129424815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092515164","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23766303,0.7213981,0.0009577198,0.012576863,0.0010280396,0.0002475183,0.0011855492,0.0000828274,0.024860358],"genre_scores_gemma":[0.7476727,0.23670708,0.0011617274,0.0086953575,0.0014936555,0.00011282038,0.00134323,0.00002951798,0.0027839767],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99884653,0.0007015598,0.00014369951,0.00007620063,0.00017938147,0.00005266653],"domain_scores_gemma":[0.99227506,0.0049914513,0.0013626077,0.0003095867,0.0007003595,0.00036098002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029992925,0.00028863398,0.00094174925,0.00051942567,0.00021207274,0.0006808174,0.0007178806,0.0006957173,0.0042926446],"category_scores_gemma":[0.005498672,0.00019203863,0.001117384,0.0006907834,0.00089531875,0.00042483394,0.00024704955,0.0012935079,0.00046583256],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12476297,0.0021026835,0.021481328,0.022489669,0.008144065,0.0007680178,0.00022079468,0.0015039576,0.015727613,0.0031721627,0.012382897,0.78724384],"study_design_scores_gemma":[0.082377076,0.1789259,0.36334637,0.019165713,0.018583028,0.005004314,0.00049114384,0.0012734686,0.014585311,0.006095398,0.30995265,0.00019962771],"about_ca_topic_score_codex":0.0016663554,"about_ca_topic_score_gemma":0.004104669,"teacher_disagreement_score":0.0042926446,"about_ca_system_score_codex":0.0006950513,"about_ca_system_score_gemma":0.0008917617,"threshold_uncertainty_score":0.015861928},"labels":[],"label_agreement":null},{"id":"W2096198028","doi":"10.1177/1756287215589250","title":"The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial","year":2015,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Solifenacin; Mirabegron; Overactive bladder; Medicine; Urology; Clinical endpoint; Nocturia; Randomized controlled trial; Population; Internal medicine; Tolerability; Confidence interval; Adverse effect; Urinary system","score_opus":0.05164584700548972,"score_gpt":0.39030958182012515,"score_spread":0.3386637348146354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096198028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948671,0.0026375658,0.00027335616,0.00030131097,0.00014255419,0.0010469093,0.00030287882,0.000023787006,0.00040458373],"genre_scores_gemma":[0.9943058,0.001553641,0.0009563958,0.00053258485,0.00033642264,0.0012463325,0.00047308108,0.000010672851,0.00058503356],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983265,0.0011226544,0.00013245807,0.00017268953,0.0001351765,0.0001104725],"domain_scores_gemma":[0.99705887,0.0011422196,0.0009636845,0.00016759969,0.0001450359,0.0005225923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037672226,0.0013640274,0.0028349673,0.00040043105,0.00042365325,0.0009551015,0.00093641126,0.0017125543,0.0038866731],"category_scores_gemma":[0.0034182877,0.0008026968,0.0025886982,0.0003851303,0.0013255203,0.00084434624,0.00043672512,0.0025982908,0.00055192603],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9810503,0.0056627253,0.0013270817,0.00038938478,0.0010563519,0.000019087898,0.000037787664,0.00017133805,0.0024173025,0.000024945031,0.00015236693,0.007691521],"study_design_scores_gemma":[0.87059784,0.12424677,0.0033809363,0.000023749073,0.00067546574,0.000029141267,0.000016300643,0.00029532268,0.00052326906,0.000033010427,0.00016750032,0.000010684984],"about_ca_topic_score_codex":0.0006082414,"about_ca_topic_score_gemma":0.0014495288,"teacher_disagreement_score":0.0038866731,"about_ca_system_score_codex":0.0007568871,"about_ca_system_score_gemma":0.001187064,"threshold_uncertainty_score":0.01992321},"labels":[],"label_agreement":null},{"id":"W2099842968","doi":"10.1177/1756287214528745","title":"Best practice in the assessment of bladder function in infants","year":2014,"lang":"en","type":"review","venue":"Therapeutic Advances in Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Clinical Practice; Function (biology); Internal medicine; Family medicine; Genetics","score_opus":0.056938284093472964,"score_gpt":0.4742088046173039,"score_spread":0.41727052052383096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099842968","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0063958396,0.6147023,0.074955545,0.1439019,0.026139442,0.0007393445,0.0026177065,0.0036084994,0.1269394],"genre_scores_gemma":[0.05302545,0.6165976,0.22276962,0.053527422,0.016997864,0.0019915318,0.003763402,0.0014100879,0.029917056],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99195963,0.0034535083,0.0016358991,0.00065265753,0.0019483872,0.0003498487],"domain_scores_gemma":[0.98058987,0.0071719345,0.0014252319,0.0012771963,0.008320121,0.0012156378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007836075,0.0015259323,0.001501441,0.004642853,0.000922682,0.0031076104,0.003253116,0.004020998,0.01209165],"category_scores_gemma":[0.03327398,0.00053958094,0.001465385,0.0023397296,0.0018031191,0.0034502002,0.0031332683,0.005080483,0.014143941],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011856957,0.00009170581,0.004633259,0.0042090863,0.00008464529,0.0027888843,0.0008156356,0.0003595427,0.00091912755,0.0042260657,0.1876787,0.79407483],"study_design_scores_gemma":[0.000048931142,0.00014363597,0.009639379,0.03298986,0.00014322739,0.015423329,0.0012390198,0.0004101687,0.0012880425,0.010498055,0.9280694,0.000107037115],"about_ca_topic_score_codex":0.005485465,"about_ca_topic_score_gemma":0.0049519693,"teacher_disagreement_score":0.01209165,"about_ca_system_score_codex":0.0014342204,"about_ca_system_score_gemma":0.0038245197,"threshold_uncertainty_score":0.04144162},"labels":[],"label_agreement":null},{"id":"W2120110014","doi":"10.1177/1756287212466128","title":"An evidence-based guide to the selection of sequential therapies in metastatic renal cell carcinoma","year":2012,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Temsirolimus; Medicine; Sorafenib; Sunitinib; Axitinib; Everolimus; Pazopanib; Renal cell carcinoma; Oncology; Bevacizumab; Internal medicine; Context (archaeology); Targeted therapy; Cancer; Hepatocellular carcinoma; Chemotherapy; PI3K/AKT/mTOR pathway; Discovery and development of mTOR inhibitors","score_opus":0.049168168976717844,"score_gpt":0.34903683080184256,"score_spread":0.2998686618251247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120110014","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023815876,0.5375603,0.15886337,0.20742403,0.020757133,0.016241595,0.009803428,0.001630557,0.045338094],"genre_scores_gemma":[0.016743282,0.25116435,0.644325,0.05195046,0.0070266393,0.01260157,0.005013274,0.0004252479,0.010750226],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97828406,0.008231768,0.009971989,0.0006732806,0.0025981986,0.00024068271],"domain_scores_gemma":[0.9369736,0.037767306,0.005656369,0.0013822125,0.016621647,0.0015987954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025431018,0.0020398593,0.0052903797,0.014764417,0.0010186615,0.004650232,0.006341313,0.004251354,0.009731907],"category_scores_gemma":[0.07010723,0.0016131604,0.0041907583,0.011170892,0.001680397,0.005169327,0.0024242327,0.0067892177,0.0054991883],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006153594,0.00028125354,0.0021154967,0.043699622,0.0015923473,0.0020058923,0.0006002522,0.0025483118,0.0014302835,0.0150368055,0.4176944,0.51237994],"study_design_scores_gemma":[0.0012863104,0.0004426616,0.004682692,0.10085453,0.0018264635,0.002816056,0.00071193266,0.004281344,0.0007043642,0.058119196,0.8240781,0.00019636097],"about_ca_topic_score_codex":0.0037590906,"about_ca_topic_score_gemma":0.011984455,"teacher_disagreement_score":0.025431018,"about_ca_system_score_codex":0.004198564,"about_ca_system_score_gemma":0.009734509,"threshold_uncertainty_score":0.13449371},"labels":[],"label_agreement":null},{"id":"W2144234476","doi":"10.1177/1756287209103923","title":"Review: Use of nomograms for predictions of outcome in patients with advanced bladder cancer","year":2009,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Nomogram; Medicine; Bladder cancer; Generalizability theory; Cystectomy; Clinical trial; Oncology; Cancer; Internal medicine; Statistics","score_opus":0.029200712434061183,"score_gpt":0.34598659169124524,"score_spread":0.31678587925718404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144234476","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003625316,0.9980909,0.00018788951,0.00046725685,0.00030959432,0.00004799032,0.00023406632,0.0000080910795,0.00029166025],"genre_scores_gemma":[0.006464687,0.99189997,0.00058972905,0.00044495176,0.00025665623,0.00007328319,0.00019778762,0.0000048794664,0.00006813444],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9938227,0.0022494055,0.0020624693,0.00046247395,0.0013203473,0.00008248166],"domain_scores_gemma":[0.9582909,0.033175647,0.0049740747,0.00044723763,0.0029087188,0.00020344692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006134178,0.001187483,0.0047759404,0.009016521,0.00042513458,0.0023840205,0.0016467762,0.0013835422,0.0025524087],"category_scores_gemma":[0.046371244,0.0005789238,0.004064007,0.010469027,0.00078965415,0.0022772667,0.0008105719,0.0011194599,0.0005178909],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026811234,0.000021799635,0.005054612,0.5773127,0.005035523,0.00023949123,0.00021020079,0.00060178636,0.00017259238,0.00086835725,0.02095575,0.38925907],"study_design_scores_gemma":[0.00018096599,0.00030469926,0.028139194,0.75099486,0.025153363,0.0027203183,0.0004615654,0.00070590107,0.00043150745,0.0014826126,0.18930556,0.00011938648],"about_ca_topic_score_codex":0.0030612098,"about_ca_topic_score_gemma":0.0049924753,"teacher_disagreement_score":0.009016521,"about_ca_system_score_codex":0.0017125655,"about_ca_system_score_gemma":0.0044154176,"threshold_uncertainty_score":0.03244102},"labels":[],"label_agreement":null},{"id":"W2158146719","doi":"10.1177/1756287212454932","title":"Penile traction therapy and Peyronie’s disease: a state of art review of the current literature","year":2012,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care","funders":"","keywords":"Peyronie's disease; Medicine; Traction (geology); Erectile dysfunction; Deformity; Penis; Disease; Surgery; Conservative treatment; Internal medicine","score_opus":0.031817417420834576,"score_gpt":0.348229579899948,"score_spread":0.3164121624791134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158146719","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027633333,0.99916923,0.000030348052,0.00017815206,0.00006847772,0.0000021530245,0.0000058881046,0.0000015854255,0.000267854],"genre_scores_gemma":[0.0012950001,0.99807334,0.00006998547,0.00013772793,0.0003237312,0.000003773408,0.000010835071,7.156748e-7,0.00008479848],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99929655,0.00016294183,0.00022819737,0.00009363201,0.00018505612,0.00003366168],"domain_scores_gemma":[0.9956052,0.0032866877,0.000655247,0.000048524595,0.00031483202,0.00008943997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012687087,0.0007570916,0.0029479756,0.0035316735,0.0003981565,0.0018701606,0.0011079352,0.0017865305,0.0038767164],"category_scores_gemma":[0.00285251,0.0003943141,0.0007982795,0.005048278,0.0008769897,0.0022864398,0.0005762678,0.0010100781,0.0008671076],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002985148,0.000212986,0.002644653,0.054987896,0.0003328319,0.003188751,0.00025953227,0.0002393707,0.00060098525,0.0009366354,0.01244297,0.923855],"study_design_scores_gemma":[0.00015910775,0.0012330884,0.027478531,0.104170665,0.0036810357,0.06902262,0.00200572,0.0005711697,0.0011309581,0.003417242,0.7869806,0.0001493227],"about_ca_topic_score_codex":0.0013963399,"about_ca_topic_score_gemma":0.002617153,"teacher_disagreement_score":0.0038767164,"about_ca_system_score_codex":0.00053045515,"about_ca_system_score_gemma":0.001647296,"threshold_uncertainty_score":0.012968898},"labels":[],"label_agreement":null},{"id":"W2166103708","doi":"10.1177/1756287214528023","title":"Innovations in the management of Wilms’ tumor","year":2014,"lang":"en","type":"review","venue":"Therapeutic Advances in Urology","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Wilms' tumor; Intensive care medicine; Disease; Internal medicine","score_opus":0.017121682689009515,"score_gpt":0.3351054226664994,"score_spread":0.31798373997748985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166103708","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000722497,0.9982211,0.00015187323,0.00039480272,0.00025279386,0.0000029069213,0.000007785627,0.000007532376,0.00088901754],"genre_scores_gemma":[0.0005935834,0.9982235,0.0002151278,0.00022461952,0.00031979874,0.000003289144,0.000017137578,0.0000017023463,0.00040117028],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997166,0.000049671115,0.00003778455,0.000049500406,0.00012165323,0.000024817506],"domain_scores_gemma":[0.9995703,0.00021406109,0.000052946914,0.000015527592,0.000103844126,0.000043345186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081207446,0.00072270277,0.0009925659,0.0027377387,0.00035877543,0.0008718591,0.00083975674,0.0010524953,0.0028257056],"category_scores_gemma":[0.0010317218,0.00022534457,0.0005903606,0.002177102,0.00067656394,0.0016683476,0.0006941593,0.0024619165,0.0017634152],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003302838,0.00004559155,0.00017625157,0.008412327,0.000049668826,0.00030537182,0.000057731035,0.00036299665,0.0008556332,0.0042135883,0.025971532,0.9595162],"study_design_scores_gemma":[0.000008166663,0.000048041966,0.00070831936,0.0024359815,0.000046440404,0.0023577877,0.000047935562,0.00007607199,0.00026420035,0.002835279,0.99115694,0.000014887079],"about_ca_topic_score_codex":0.0010574602,"about_ca_topic_score_gemma":0.0016554625,"teacher_disagreement_score":0.0028257056,"about_ca_system_score_codex":0.0007629043,"about_ca_system_score_gemma":0.0010613727,"threshold_uncertainty_score":0.009452939},"labels":[],"label_agreement":null},{"id":"W2285484581","doi":"10.1177/1756287215621471","title":"Degarelix monotherapy compared with luteinizing hormone-releasing hormone (LHRH) agonists plus anti-androgen flare protection in advanced prostate cancer: an analysis of two randomized controlled trials","year":2015,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Prostate cancer; Hazard ratio; Urology; Internal medicine; Proportional hazards model; Bicalutamide; Hormone antagonist; Luteinizing hormone; Goserelin; Population; Agonist; Antiandrogen; Oncology; Gynecology; Confidence interval; Cancer; Hormone; Endocrine system; Androgen receptor; Receptor","score_opus":0.0447651738103733,"score_gpt":0.35837599128989234,"score_spread":0.313610817479519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2285484581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81066036,0.17637359,0.003719669,0.0008640679,0.0013205513,0.004997299,0.0008774602,0.00014261993,0.0010444648],"genre_scores_gemma":[0.96746576,0.023904772,0.002752423,0.00085876626,0.00078643294,0.0030363977,0.000585688,0.000030735424,0.0005791158],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9824086,0.012505834,0.0019180466,0.0014387203,0.0012727375,0.0004559946],"domain_scores_gemma":[0.9778284,0.014337864,0.0050164685,0.001145616,0.00078524894,0.0008863523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019220145,0.001821132,0.009976776,0.0015637751,0.0005074544,0.002358313,0.0013641657,0.0026938873,0.0028494613],"category_scores_gemma":[0.021664789,0.0010503978,0.012256869,0.0015959692,0.0012367677,0.00171156,0.00065788557,0.0021982517,0.0002205443],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91469514,0.0013490696,0.0027056544,0.005357045,0.0578827,0.00007379954,0.00005468022,0.00041635192,0.00095814554,0.00011968708,0.00022262293,0.01616508],"study_design_scores_gemma":[0.87324435,0.053738933,0.0090782605,0.00061913574,0.060581874,0.00008970697,0.00005570861,0.0012009267,0.0003622373,0.00031806796,0.00066071603,0.000050089842],"about_ca_topic_score_codex":0.00076253765,"about_ca_topic_score_gemma":0.00124867,"teacher_disagreement_score":0.019220145,"about_ca_system_score_codex":0.0012563368,"about_ca_system_score_gemma":0.0014387744,"threshold_uncertainty_score":0.10164708},"labels":[],"label_agreement":null},{"id":"W2290464829","doi":"10.1177/1756287215617872","title":"Androgen deprivation therapy and cardiovascular disease: what is the linking mechanism?","year":2015,"lang":"en","type":"review","venue":"Therapeutic Advances in Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; Population Health Research Institute; McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Androgen deprivation therapy; Prostate cancer; Mechanism (biology); Disease; Adverse effect; Observational study; Hormonal therapy; Androgen; Intensive care medicine; Internal medicine; Bioinformatics; Oncology; Hormone; Cancer","score_opus":0.09196722086384265,"score_gpt":0.3869940597528789,"score_spread":0.29502683888903625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2290464829","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000056494115,0.99910104,0.000034382567,0.00040132942,0.00010032255,0.00000141187,0.000007972606,0.0000021654134,0.0002948953],"genre_scores_gemma":[0.00039462352,0.9991049,0.00005100709,0.00014210233,0.0001819622,0.0000016288011,0.0000082061815,3.726562e-7,0.000115156145],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997929,0.000043124117,0.00004021738,0.000036207122,0.00006913549,0.000018574676],"domain_scores_gemma":[0.99950564,0.00027871615,0.000072597286,0.000011119997,0.000099067795,0.00003298245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005694482,0.0005828117,0.0014181377,0.0017437306,0.000390055,0.0012832046,0.0007866833,0.001209187,0.0032227202],"category_scores_gemma":[0.001011142,0.00023842278,0.0005628301,0.0019063124,0.00062539766,0.0015579818,0.0005899086,0.0016066403,0.0010284837],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009609842,0.00007434881,0.0006541875,0.024610253,0.00017803932,0.00038074725,0.00010413921,0.00027995094,0.0007555152,0.0044451756,0.025054123,0.94336754],"study_design_scores_gemma":[0.000025754765,0.00015886365,0.0028672356,0.010998844,0.0003237201,0.003924196,0.00023320486,0.00014726279,0.0003752856,0.005183428,0.9757224,0.000039815764],"about_ca_topic_score_codex":0.0015792405,"about_ca_topic_score_gemma":0.0026862207,"teacher_disagreement_score":0.0032227202,"about_ca_system_score_codex":0.0005113778,"about_ca_system_score_gemma":0.0015930975,"threshold_uncertainty_score":0.010781109},"labels":[],"label_agreement":null},{"id":"W2398715868","doi":"10.1177/1756287215592288","title":"Abiraterone in the management of castration-resistant prostate cancer prior to chemotherapy","year":2015,"lang":"en","type":"review","venue":"Therapeutic Advances in Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Abiraterone acetate; Enzalutamide; Cabazitaxel; Prostate cancer; Docetaxel; Oncology; Internal medicine; Adverse effect; Chemotherapy; Androgen deprivation therapy; Cancer; Pharmacology; Androgen receptor","score_opus":0.07728953142386998,"score_gpt":0.4469508642662002,"score_spread":0.3696613328423302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398715868","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019325438,0.99900776,0.000039984643,0.000073623574,0.00005388779,0.0000032835949,0.000010319661,0.0000038219578,0.00061413477],"genre_scores_gemma":[0.0012564155,0.99822456,0.000086975386,0.000082824,0.000056093708,0.0000033747663,0.000020215239,8.9251586e-7,0.0002686409],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998066,0.00003662799,0.000040537925,0.000023987299,0.00007714301,0.000015132986],"domain_scores_gemma":[0.9997987,0.00010814885,0.000037457314,0.0000049383643,0.00003744331,0.0000133602625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035907398,0.0003903738,0.0009912295,0.0020217404,0.00019572768,0.00060710305,0.0005462778,0.00047619463,0.0026790586],"category_scores_gemma":[0.0006002577,0.00017671614,0.00050917594,0.0014761223,0.00024059675,0.00048618542,0.00036490388,0.0011013887,0.00095524493],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012542598,0.000072097486,0.00023543875,0.027234301,0.00013843196,0.00029673707,0.00007601661,0.0003151414,0.0012147651,0.0011908481,0.013774758,0.95532614],"study_design_scores_gemma":[0.0000578087,0.00018342085,0.0019302932,0.010349239,0.00031432847,0.0033228386,0.00008210617,0.00012637446,0.000682663,0.0011508117,0.9817794,0.000020593758],"about_ca_topic_score_codex":0.0012818176,"about_ca_topic_score_gemma":0.0033542137,"teacher_disagreement_score":0.0026790586,"about_ca_system_score_codex":0.00039539687,"about_ca_system_score_gemma":0.0008077899,"threshold_uncertainty_score":0.008962333},"labels":[],"label_agreement":null},{"id":"W2407495396","doi":"10.1177/1756287216650132","title":"Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia","year":2016,"lang":"en","type":"review","venue":"Therapeutic Advances in Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Tadalafil; Finasteride; Lower urinary tract symptoms; Combination therapy; Erectile dysfunction; Urology; Adverse effect; Benign prostatic hyperplasia (BPH); Hyperplasia; Overactive bladder; cGMP-specific phosphodiesterase type 5; Urinary system; Internal medicine; Prostate; Pathology; Alternative medicine","score_opus":0.06022348240482115,"score_gpt":0.38372638090207234,"score_spread":0.32350289849725117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407495396","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1209842,0.86019707,0.00039283372,0.0066525815,0.00092063437,0.00024559005,0.0009144945,0.000028071976,0.00966458],"genre_scores_gemma":[0.6573359,0.32780856,0.001500041,0.0075024227,0.0030051002,0.00018996566,0.0012698113,0.000020579117,0.0013676288],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9954423,0.0021842972,0.0007821243,0.00041963026,0.0010261503,0.00014552796],"domain_scores_gemma":[0.97583586,0.017221265,0.0039804773,0.0005846182,0.0015310169,0.0008468127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054365466,0.00048879575,0.002318192,0.001031361,0.0004134448,0.001274055,0.0011509714,0.001924647,0.009193372],"category_scores_gemma":[0.014721985,0.000508936,0.0038307018,0.00139125,0.0012782107,0.00087804196,0.00063457584,0.0023725484,0.00073779305],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19387348,0.0039030223,0.027827954,0.07395801,0.056726266,0.000683321,0.00045736818,0.00078553666,0.008677971,0.001996948,0.0071913754,0.6239187],"study_design_scores_gemma":[0.1212226,0.17998785,0.39146912,0.044582564,0.12373523,0.00383052,0.0009712844,0.0011510305,0.0045999615,0.0043800874,0.12380904,0.00026066],"about_ca_topic_score_codex":0.001343023,"about_ca_topic_score_gemma":0.0029458238,"teacher_disagreement_score":0.009193372,"about_ca_system_score_codex":0.0007577286,"about_ca_system_score_gemma":0.0012328869,"threshold_uncertainty_score":0.030754864},"labels":[],"label_agreement":null},{"id":"W2514283099","doi":"10.1177/1756287216663073","title":"Cabozantinib in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience","year":2016,"lang":"en","type":"review","venue":"Therapeutic Advances in Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"FP7 Science in Society; Bristol-Myers Squibb","keywords":"Cabozantinib; Medicine; Sunitinib; Axitinib; Oncology; Metastasis; Renal cell carcinoma; Internal medicine; Targeted therapy; Tyrosine-kinase inhibitor; Cancer research; Vascular endothelial growth factor; Angiogenesis; Tyrosine kinase; Everolimus; Receptor tyrosine kinase; Cancer; Receptor; VEGF receptors","score_opus":0.1681734959571597,"score_gpt":0.4580039289744441,"score_spread":0.2898304330172844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514283099","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035455855,0.9988865,0.000034266875,0.00012628574,0.000055192362,0.000013346762,0.00002945519,0.0000030260621,0.0004973281],"genre_scores_gemma":[0.003899274,0.99529254,0.00015949199,0.00026930773,0.000061014267,0.000022597489,0.00006966294,0.0000023714565,0.00022379731],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99965763,0.00012027368,0.00007325084,0.000037708385,0.000091570626,0.000019559475],"domain_scores_gemma":[0.9989743,0.00059537345,0.00017350091,0.000021907788,0.00017834133,0.000056497185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016055745,0.0005592342,0.002064014,0.0008245297,0.00014446441,0.0008291431,0.0010039728,0.00070574007,0.0029304898],"category_scores_gemma":[0.0021914346,0.00015086935,0.0011824161,0.0014137035,0.0002449095,0.0005291904,0.00032447296,0.0010666299,0.00049108925],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002692572,0.00015808252,0.00039043982,0.09743988,0.0017878049,0.0001573895,0.000093056085,0.0005087337,0.0013884516,0.0014579226,0.018862028,0.87506366],"study_design_scores_gemma":[0.0028911727,0.0029467861,0.0064928355,0.08405299,0.011441283,0.0017880782,0.00020199659,0.00050316326,0.0018167811,0.0026066625,0.8851787,0.00007960808],"about_ca_topic_score_codex":0.0010067472,"about_ca_topic_score_gemma":0.0026797378,"teacher_disagreement_score":0.0029304898,"about_ca_system_score_codex":0.0005648168,"about_ca_system_score_gemma":0.0010816988,"threshold_uncertainty_score":0.009803474},"labels":[],"label_agreement":null},{"id":"W2613863892","doi":"10.1177/1756287217702797","title":"Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies","year":2017,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Astellas Pharma Global Development; Astellas Pharma Europe; European Association of Urology","keywords":"Mirabegron; Solifenacin; Tolterodine; Overactive bladder; Medicine; Urination; Urology; Placebo; Adverse effect; Lower urinary tract symptoms; Urinary incontinence; Internal medicine; Urinary system; Prostate","score_opus":0.031208004121444713,"score_gpt":0.4128818922531041,"score_spread":0.3816738881316594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613863892","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29582742,0.68752104,0.0043584406,0.0018468515,0.0006104048,0.005636929,0.0018330893,0.00016688119,0.002198887],"genre_scores_gemma":[0.90621567,0.081753716,0.004163377,0.002409966,0.00048501015,0.0026718217,0.0018286392,0.00007140983,0.00040037523],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9823461,0.010319978,0.00371121,0.001208793,0.0019105221,0.000503428],"domain_scores_gemma":[0.9573641,0.020425478,0.0152862435,0.002032561,0.0036139654,0.0012776848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.041246515,0.0016749629,0.007404153,0.0016137748,0.00065315724,0.0033305362,0.0014928053,0.002158304,0.0017662814],"category_scores_gemma":[0.033630442,0.0011018498,0.016574133,0.001627945,0.001405104,0.0015621873,0.0010479315,0.0021432308,0.00022822796],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42581218,0.001342539,0.022024065,0.06680384,0.34092206,0.0003692384,0.0006311586,0.0022190018,0.009867317,0.0006014912,0.0027611393,0.12664598],"study_design_scores_gemma":[0.21916047,0.09277501,0.087509066,0.015481572,0.5571577,0.0010466126,0.00039628858,0.0019684876,0.005066509,0.0014159215,0.017719693,0.00030274616],"about_ca_topic_score_codex":0.000720838,"about_ca_topic_score_gemma":0.0016746904,"teacher_disagreement_score":0.041246515,"about_ca_system_score_codex":0.0022830975,"about_ca_system_score_gemma":0.002215856,"threshold_uncertainty_score":0.21813506},"labels":[],"label_agreement":null},{"id":"W2888229344","doi":"10.1177/1756287218794094","title":"The contemporary role of lymph node dissection in the management of renal cell carcinoma","year":2018,"lang":"en","type":"review","venue":"Therapeutic Advances in Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital","funders":"National Cancer Institute","keywords":"Medicine; Renal cell carcinoma; Lymph node; Nephrectomy; Dissection (medical); Disease; Systemic therapy; Oncology; Kidney cancer; Internal medicine; Adjuvant; Randomized controlled trial; Clinical trial; Cancer; Surgery; Kidney","score_opus":0.038821155564756724,"score_gpt":0.32760745649240836,"score_spread":0.2887863009276516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888229344","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043790304,0.9993292,0.000036752954,0.00022870136,0.00009348962,0.0000016488615,0.000006096551,0.000001984352,0.00025841736],"genre_scores_gemma":[0.0003273845,0.9992067,0.00007987388,0.00017509598,0.00010528612,0.000002561293,0.000009977729,7.1277526e-7,0.00009236436],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963415,0.000092591676,0.000074653806,0.000055328786,0.00012086589,0.000022480644],"domain_scores_gemma":[0.99915755,0.00048218164,0.00011602903,0.000020276088,0.00018264305,0.000041363848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010300988,0.0005651957,0.0014117802,0.0019506076,0.00027529013,0.0009184815,0.0010890762,0.0010347323,0.0024346414],"category_scores_gemma":[0.0016726499,0.00022971841,0.0006066218,0.0023464262,0.00064393197,0.0013898179,0.00061905966,0.0019460114,0.0010185863],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060762522,0.000029850473,0.00013344515,0.024840696,0.00010961636,0.00007615021,0.000062010375,0.00027468003,0.00040478862,0.0022688792,0.01805401,0.95368516],"study_design_scores_gemma":[0.00002945188,0.00011321219,0.0012685097,0.016493758,0.0002924071,0.0010676855,0.00010684607,0.00011055283,0.00018027739,0.0024621782,0.97785085,0.00002420274],"about_ca_topic_score_codex":0.0015828363,"about_ca_topic_score_gemma":0.0030580868,"teacher_disagreement_score":0.0024346414,"about_ca_system_score_codex":0.0007255562,"about_ca_system_score_gemma":0.0013688104,"threshold_uncertainty_score":0.008144677},"labels":[],"label_agreement":null},{"id":"W2892788943","doi":"10.1177/1756287218801282","title":"Mirabegron, alone and in combination, in the treatment of overactive bladder: real-world evidence and experience","year":2018,"lang":"en","type":"review","venue":"Therapeutic Advances in Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Mirabegron; Nocturia; Overactive bladder; Medicine; Distressing; Urology; Agonist; Urinary urgency; Population; Internal medicine; Intensive care medicine; Receptor; Urinary system; Alternative medicine; Pathology","score_opus":0.10815439610379826,"score_gpt":0.45778623516372985,"score_spread":0.34963183905993156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892788943","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013514423,0.99939597,0.000022515964,0.00009257932,0.000035009798,0.000001952399,0.000010313732,0.000001282151,0.0003053028],"genre_scores_gemma":[0.0009700366,0.99870145,0.000085021784,0.000107429136,0.000053406176,0.0000026387836,0.000014184818,7.6072155e-7,0.0000650357],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996973,0.000076776734,0.00007846414,0.00004421895,0.0000876945,0.000015579466],"domain_scores_gemma":[0.9990735,0.0006459163,0.00012914317,0.000013043258,0.00011166895,0.000026749223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082861236,0.00048060727,0.0013040663,0.0017679377,0.0001787138,0.00090027857,0.00061625487,0.0006576835,0.0030903353],"category_scores_gemma":[0.0017151756,0.00017686146,0.0007166048,0.0022924806,0.00031152452,0.00077071757,0.00039667994,0.0010045446,0.00059500086],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028459507,0.000081146565,0.00043703857,0.07377453,0.0004279128,0.0003136331,0.00011881679,0.00026096887,0.0008376324,0.0014696919,0.012833058,0.909161],"study_design_scores_gemma":[0.00012923453,0.00046216286,0.0038390472,0.06443724,0.0027305305,0.006086693,0.0002952109,0.000186724,0.0007899873,0.0017429931,0.9192453,0.000054920896],"about_ca_topic_score_codex":0.00069852854,"about_ca_topic_score_gemma":0.0017296877,"teacher_disagreement_score":0.0030903353,"about_ca_system_score_codex":0.00036507632,"about_ca_system_score_gemma":0.0007828339,"threshold_uncertainty_score":0.010338128},"labels":[],"label_agreement":null},{"id":"W2935132740","doi":"10.1177/1756287219838364","title":"Meta-analysis of randomized controlled trials that assess the efficacy of low-intensity shockwave therapy for the treatment of erectile dysfunction","year":2019,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Erectile dysfunction; Extracorporeal shockwave therapy; Randomized controlled trial; Meta-analysis; Erectile function; Strictly standardized mean difference; Internal medicine; Urology; Physical therapy","score_opus":0.1860381155515789,"score_gpt":0.4002952836008973,"score_spread":0.21425716804931838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2935132740","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009504886,0.9855198,0.0017792274,0.00032162922,0.0004189567,0.001223146,0.0007052056,0.000059866237,0.00046729972],"genre_scores_gemma":[0.32953995,0.647422,0.011153308,0.0018100549,0.00082204636,0.0067392886,0.0018689332,0.00009821905,0.00054618384],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9532796,0.027669493,0.0126068145,0.002827472,0.0030426173,0.00057396514],"domain_scores_gemma":[0.92541283,0.059000578,0.011071051,0.001742839,0.0023128723,0.00045984212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.040474582,0.0046863044,0.029653963,0.011046627,0.0009157935,0.005040981,0.0030138444,0.003300334,0.004541867],"category_scores_gemma":[0.09048218,0.0019429899,0.055052377,0.0094476305,0.0009886948,0.0026141054,0.0017425433,0.002662937,0.00040167704],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030515196,0.00003571295,0.0023276878,0.1651447,0.8233088,0.000083561215,0.00003912598,0.00048495995,0.00015236951,0.00010871136,0.00022933786,0.005033457],"study_design_scores_gemma":[0.0010975706,0.00028260282,0.0015604169,0.010465798,0.9853914,0.00005885914,0.000023696322,0.00017448237,0.000105687606,0.00019109376,0.0006333064,0.0000151905415],"about_ca_topic_score_codex":0.0027597162,"about_ca_topic_score_gemma":0.005705272,"teacher_disagreement_score":0.040474582,"about_ca_system_score_codex":0.0031195618,"about_ca_system_score_gemma":0.0033117884,"threshold_uncertainty_score":0.21405262},"labels":[],"label_agreement":null},{"id":"W2980989046","doi":"10.1177/1756287219882809","title":"Incorporating mpMRI biopsy data into established pre-RP nomograms: potential impact of an increasingly common clinical scenario","year":2019,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Nomogram; Medicine; Biopsy; Radiology; Multiparametric MRI; Oncology; Urology; Prostate cancer; Internal medicine; Cancer","score_opus":0.03093096080422956,"score_gpt":0.4008959193652533,"score_spread":0.36996495856102374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980989046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94640195,0.004493409,0.034796413,0.00494102,0.000205845,0.00018540677,0.0015833385,0.00011591046,0.007276577],"genre_scores_gemma":[0.9897983,0.00053626957,0.008669546,0.0002817347,0.0001190039,0.000043312313,0.0004458898,0.000021456632,0.00008440499],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.97771627,0.015857577,0.0017210117,0.0015173823,0.0027334876,0.0004542782],"domain_scores_gemma":[0.85773283,0.0945114,0.024318915,0.009753006,0.01161377,0.0020702302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03692366,0.0006045843,0.00062165497,0.002031363,0.00045013556,0.0028330146,0.0014877114,0.00071398995,0.0011130436],"category_scores_gemma":[0.0990393,0.00028603096,0.00074847933,0.0017106028,0.00090267754,0.0026189312,0.0020227847,0.0012584075,0.00034924544],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032932058,0.00005106757,0.9529731,0.00016888538,0.00019441443,0.00017825692,0.00029130842,0.0035580467,0.0003593621,0.0005753683,0.0006662398,0.040654477],"study_design_scores_gemma":[0.00007745418,0.0010407006,0.9120131,0.0007878792,0.0003628157,0.0025070528,0.0015995279,0.064356565,0.0019926114,0.004990894,0.010181383,0.000090095964],"about_ca_topic_score_codex":0.0017652047,"about_ca_topic_score_gemma":0.0048466446,"teacher_disagreement_score":0.03692366,"about_ca_system_score_codex":0.00072754826,"about_ca_system_score_gemma":0.0013606955,"threshold_uncertainty_score":0.19527334},"labels":[],"label_agreement":null},{"id":"W3116484428","doi":"10.1177/1756287220980192","title":"Enfortumab Vedotin in urothelial cancer","year":2020,"lang":"en","type":"review","venue":"Therapeutic Advances in Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Oncology; Internal medicine; Clinical trial; Durvalumab; Cancer; Urothelial cancer; Rash; Population; Bladder cancer; Nivolumab; Immunotherapy","score_opus":0.050860074363769485,"score_gpt":0.4063818328462285,"score_spread":0.355521758482459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116484428","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028575124,0.9982755,0.000064303196,0.00015924638,0.000105223524,0.0000072368216,0.000027676355,0.000008131567,0.0010669911],"genre_scores_gemma":[0.0016095947,0.9972466,0.00013112208,0.0001994467,0.000059791917,0.00000938183,0.00005280011,0.0000015683637,0.0006897313],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988043,0.000022929553,0.000019866216,0.0000201957,0.000042298245,0.000014170069],"domain_scores_gemma":[0.9998895,0.00005008363,0.000022413422,0.000002773172,0.000025483234,0.000009711859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035617198,0.00048779877,0.00082877383,0.0015050066,0.00017434474,0.0006328621,0.000501955,0.0006016762,0.0047532055],"category_scores_gemma":[0.00040474895,0.0001733599,0.0006004823,0.0010949606,0.0001723346,0.00060644123,0.00045031623,0.0010026228,0.0014903388],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010697531,0.00006512322,0.00012393954,0.02534272,0.00011489347,0.00014216258,0.000042335367,0.00028755036,0.0018227968,0.0015361753,0.015974429,0.95444095],"study_design_scores_gemma":[0.00006235341,0.00021078905,0.0010568294,0.0070388536,0.0002854716,0.0013973523,0.000042636166,0.00013617704,0.00088912476,0.0010147241,0.98785156,0.000014163135],"about_ca_topic_score_codex":0.00083476526,"about_ca_topic_score_gemma":0.002228026,"teacher_disagreement_score":0.0047532055,"about_ca_system_score_codex":0.00036312104,"about_ca_system_score_gemma":0.00069449644,"threshold_uncertainty_score":0.01590103},"labels":[],"label_agreement":null},{"id":"W3194907215","doi":"10.1177/17562872211039583","title":"Multiparametric magnetic resonance imaging for bladder cancer: a comprehensive systematic review of the Vesical Imaging-Reporting and Data System (VI-RADS) performance and potential clinical applications","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Bladder cancer; Magnetic resonance imaging; Prospective cohort study; Retrospective cohort study; MEDLINE; Cancer; Radiology; Medical physics; Internal medicine","score_opus":0.07545497741378115,"score_gpt":0.43436978318095215,"score_spread":0.358914805767171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194907215","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00085158146,0.99805295,0.00016725654,0.00024301893,0.000048808954,0.00011898897,0.0003812629,0.0000062884205,0.00012995304],"genre_scores_gemma":[0.017437086,0.97981673,0.0011994475,0.0004688073,0.0000903757,0.0004832384,0.00044578587,0.00000818453,0.000050329578],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9810994,0.006519516,0.0078089884,0.0012210903,0.0029995965,0.0003514006],"domain_scores_gemma":[0.91260225,0.065674484,0.0142689785,0.0011732669,0.0058913254,0.00038971248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021042554,0.0015282787,0.006747325,0.014769114,0.0005917969,0.0026633167,0.0020182051,0.0018752009,0.0022851937],"category_scores_gemma":[0.07600648,0.0009499784,0.010004144,0.015741734,0.0010118787,0.0024518406,0.0014700987,0.0012227946,0.00025232093],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017959948,0.0000137090265,0.0023224382,0.9378809,0.0133806765,0.000067112065,0.00017384235,0.00015471062,0.00017767085,0.0002423593,0.0014993188,0.043907646],"study_design_scores_gemma":[0.00017018858,0.00019346309,0.010514273,0.8675986,0.105096854,0.0004264698,0.00024571325,0.00018728012,0.00027076082,0.00034260328,0.014891784,0.00006193916],"about_ca_topic_score_codex":0.008194236,"about_ca_topic_score_gemma":0.020313285,"teacher_disagreement_score":0.021042554,"about_ca_system_score_codex":0.0033781244,"about_ca_system_score_gemma":0.012213522,"threshold_uncertainty_score":0.11128497},"labels":[],"label_agreement":null},{"id":"W4317627227","doi":"10.1177/17562872221150572","title":"Insights from the AQUA Registry: a retrospective study of anticholinergic polypharmacy in the United States","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"Astellas Pharma Global Development; Astellas Pharma","keywords":"Medicine; Polypharmacy; Overactive bladder; Anticholinergic; Beers Criteria; Retrospective cohort study; Pharmacy; Population; Internal medicine; Cohort; Emergency medicine; Family medicine; Alternative medicine; Environmental health","score_opus":0.0430127379108816,"score_gpt":0.3823588522476854,"score_spread":0.3393461143368038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317627227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920089,0.00078063406,0.00031656877,0.00025844685,0.000016416128,0.000070596434,0.005462814,0.000014041928,0.0010715084],"genre_scores_gemma":[0.99478585,0.0004501565,0.00032148688,0.00027987504,0.000027771064,0.00008165904,0.0039276453,0.000007703498,0.0001179329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972167,0.00087050674,0.0005539571,0.00052189175,0.000607896,0.00022898792],"domain_scores_gemma":[0.9914438,0.0012365639,0.004999113,0.00079565874,0.00089418015,0.0006305706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029489456,0.000233606,0.00046133006,0.0014487478,0.0005976261,0.0010259002,0.0005769223,0.00042306026,0.0009967957],"category_scores_gemma":[0.007891958,0.00041528925,0.00048307207,0.002823852,0.00031660107,0.001081585,0.0013484707,0.0005879144,0.00022548254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016734624,0.0000122614,0.99898297,0.000009837703,0.000025479805,0.000036176134,0.00006733385,0.000009478789,0.000021326056,0.00001612993,0.0002794165,0.00052286376],"study_design_scores_gemma":[0.00000715529,0.000042864234,0.99826545,0.00003258729,0.00004272931,0.00039889332,0.00039279333,0.00015177617,0.000031914264,0.000024357201,0.0006049717,0.0000045365955],"about_ca_topic_score_codex":0.0170327,"about_ca_topic_score_gemma":0.024270015,"teacher_disagreement_score":0.0170327,"about_ca_system_score_codex":0.00066104,"about_ca_system_score_gemma":0.0010658533,"threshold_uncertainty_score":0.03386712},"labels":[],"label_agreement":null},{"id":"W4323967462","doi":"10.1177/17562872231158072","title":"RIRS with disposable or reusable scopes: does it make a difference? Results from the multicenter FLEXOR study","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Kidney Stones and Urolithiasis Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Surgery; Multivariate analysis; Retrospective cohort study; Internal medicine","score_opus":0.03089605707392252,"score_gpt":0.33566552180325215,"score_spread":0.30476946472932964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323967462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759185,0.0016145534,0.00010622123,0.000059830985,0.000007842738,0.000013293892,0.00022040428,0.0000025221152,0.00038346008],"genre_scores_gemma":[0.99911517,0.00033988102,0.00009124537,0.00005352694,0.00003766399,0.000010453089,0.00030431923,0.000004136744,0.000043573236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99557626,0.0020155206,0.0006830862,0.00074087136,0.00071092177,0.00027328686],"domain_scores_gemma":[0.98095554,0.0046193656,0.010958889,0.0020009894,0.0007007865,0.0007643991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008117173,0.0004383313,0.0007829872,0.0011826437,0.0001975081,0.0010251225,0.000723929,0.0005308955,0.0020678786],"category_scores_gemma":[0.01467091,0.00024370059,0.001488425,0.0020037175,0.0005312468,0.001502297,0.000669059,0.00034878627,0.00027090317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014977212,0.0000352603,0.99400747,0.000074243435,0.00037445995,0.00007113592,0.000118333206,0.000023364473,0.0001653447,0.00005106591,0.000084852974,0.0034967659],"study_design_scores_gemma":[0.0001549218,0.0012220613,0.9959842,0.00010188332,0.00055366516,0.00060416193,0.00051123096,0.0001522238,0.00017589745,0.00004821434,0.00047843673,0.000013043751],"about_ca_topic_score_codex":0.0005629655,"about_ca_topic_score_gemma":0.00068384997,"teacher_disagreement_score":0.008117173,"about_ca_system_score_codex":0.0002272673,"about_ca_system_score_gemma":0.00033756805,"threshold_uncertainty_score":0.04292822},"labels":[],"label_agreement":null},{"id":"W4366316326","doi":"10.1177/17562872231164803","title":"Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review","year":2023,"lang":"en","type":"review","venue":"Therapeutic Advances in Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Radiomics; Renal cell carcinoma; Renal oncocytoma; Angiomyolipoma; Kidney cancer; Clear cell; Clear cell renal cell carcinoma; Oncocytoma; Pathology; Radiology; Kidney; Internal medicine","score_opus":0.20484533714913908,"score_gpt":0.4457634553013434,"score_spread":0.24091811815220435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366316326","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008410571,0.9994025,0.000069071735,0.00010293092,0.00004621654,0.000004064491,0.000014308673,0.0000030037145,0.00027378363],"genre_scores_gemma":[0.00078568386,0.99871945,0.00019271133,0.00010287106,0.00007581642,0.000006615774,0.000024543713,0.0000010908353,0.000091264206],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99958366,0.00008371353,0.000120782126,0.000068861526,0.0001206503,0.000022283482],"domain_scores_gemma":[0.9984646,0.0010893897,0.000163572,0.000026604026,0.00022349053,0.000032317173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092939415,0.00093782105,0.0017559554,0.0057341573,0.00029858976,0.0011177964,0.00088724674,0.0009857701,0.0033653504],"category_scores_gemma":[0.0021634148,0.00032099953,0.0012226589,0.0059626317,0.0005262789,0.0014789876,0.0006096732,0.00088196027,0.0007343818],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008817432,0.000047744903,0.00060772203,0.08880901,0.0003564891,0.00027154371,0.00011465648,0.00034479823,0.00050911534,0.0016684169,0.014299772,0.8928827],"study_design_scores_gemma":[0.000056160243,0.00024225701,0.0077748066,0.09876825,0.0031793574,0.0070938994,0.00037255537,0.00051152846,0.00093307096,0.004142642,0.87682056,0.00010500193],"about_ca_topic_score_codex":0.0022631094,"about_ca_topic_score_gemma":0.0027621842,"teacher_disagreement_score":0.0057341573,"about_ca_system_score_codex":0.00075839536,"about_ca_system_score_gemma":0.0017923514,"threshold_uncertainty_score":0.011258185},"labels":[],"label_agreement":null},{"id":"W4380629838","doi":"10.1177/17562872231179009","title":"Under pressure: irrigation practice patterns during flexible ureteroscopy","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Kidney Stones and Urolithiasis Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Coloplast; Boston Scientific Corporation","keywords":"Medicine; Irrigation; Checklist","score_opus":0.021876789695512645,"score_gpt":0.35582030245849405,"score_spread":0.3339435127629814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380629838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975177,0.00058141054,0.00030843608,0.0003811224,0.000011112644,0.000017796981,0.00017406141,0.000016312097,0.0009920988],"genre_scores_gemma":[0.99916434,0.00025982197,0.00027010049,0.00008602382,0.00001022154,0.000009377309,0.00009775248,0.0000040531804,0.000098360324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832255,0.00058214494,0.00032099223,0.0002075395,0.0003868322,0.00018001071],"domain_scores_gemma":[0.98449534,0.004716993,0.008489583,0.0003205677,0.001235263,0.00074239005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017043321,0.0001333657,0.00014132845,0.0007299936,0.00025186257,0.00056998094,0.00035102273,0.0004254135,0.0017912688],"category_scores_gemma":[0.012710676,0.00011962914,0.000211658,0.00084616087,0.00036617028,0.00090338313,0.0006416671,0.0002856206,0.000308381],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051087034,0.00002055495,0.9840714,0.0000760585,0.0000166275,0.00008911878,0.0011195982,0.00004923987,0.00026603416,0.000010467778,0.0003715835,0.013858161],"study_design_scores_gemma":[0.0000021592068,0.00010135927,0.99534947,0.00008202228,0.000010321562,0.00070119416,0.0025984682,0.00015270415,0.0001886857,0.000023373896,0.00078202895,0.0000082981815],"about_ca_topic_score_codex":0.0022180732,"about_ca_topic_score_gemma":0.0028864571,"teacher_disagreement_score":0.0022180732,"about_ca_system_score_codex":0.00036939027,"about_ca_system_score_gemma":0.0005617718,"threshold_uncertainty_score":0.009013474},"labels":[],"label_agreement":null},{"id":"W4386576323","doi":"10.1177/17562872231198629","title":"Does unenhanced computerized tomography as imaging standard post-retrograde intrarenal surgery paradoxically reduce stone-free rate and increase additional treatment for residual fragments? Outcomes from 5395 patients in the FLEXOR study by the TOWER group","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Kidney Stones and Urolithiasis Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Propensity score matching; Confidence interval; Logistic regression; Renal function; Retrospective cohort study; Cohort; Odds ratio; Kidney stones; Ultrasound; Urology; Surgery; Internal medicine; Radiology","score_opus":0.01422406998631516,"score_gpt":0.30785135490785354,"score_spread":0.2936272849215384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386576323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99938405,0.00028750199,0.000039345177,0.000021281823,0.0000035234682,0.0000063055145,0.00017923614,0.0000013556846,0.0000772748],"genre_scores_gemma":[0.999356,0.000113607566,0.00004986532,0.000021872018,0.000011103264,0.000006575462,0.0003897925,0.0000013310524,0.00004987645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927884,0.00022090484,0.000116599775,0.00017636642,0.00012180377,0.00008537083],"domain_scores_gemma":[0.9977174,0.00036533366,0.0012875115,0.00030899423,0.000096362,0.0002244791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014768878,0.00037081607,0.00053224224,0.00056690135,0.00019999515,0.0005604989,0.000404441,0.00041303647,0.0012408101],"category_scores_gemma":[0.002825821,0.00023912193,0.0010898873,0.0006881315,0.000273331,0.00046226548,0.0004453691,0.00036611964,0.00020492991],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022439163,0.00006710107,0.9941338,0.000024980063,0.00026394488,0.00007583467,0.000050512586,0.000056619825,0.00021110715,0.000014777181,0.00012336444,0.0027340762],"study_design_scores_gemma":[0.00030216714,0.0013823776,0.9965558,0.000021592883,0.0003813147,0.0004785408,0.00014570742,0.00031660986,0.00017176523,0.000019944973,0.00021291606,0.000011232065],"about_ca_topic_score_codex":0.0012620703,"about_ca_topic_score_gemma":0.0016504751,"teacher_disagreement_score":0.0014768878,"about_ca_system_score_codex":0.00037105384,"about_ca_system_score_gemma":0.0002898078,"threshold_uncertainty_score":0.0078105927},"labels":[],"label_agreement":null},{"id":"W4387028745","doi":"10.1177/17562872231196685","title":"Chronic scrotal content pain: the experiences of patients undergoing microsurgical spermatic cord denervation","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Male Reproductive Health Studies","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Stan Cassidy Foundation; University of Northern British Columbia","funders":"","keywords":"Medicine; Chronic pain; Scrotal Pain; Spermatic cord; Scrotum; Pain medicine; Quality of life (healthcare); Physical therapy; Surgery; General surgery; Anesthesiology; Nursing; Anesthesia","score_opus":0.11325932053298315,"score_gpt":0.4252454633828673,"score_spread":0.31198614284988413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387028745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99529296,0.00084325887,0.00029935324,0.0015853836,0.000047986952,0.000042725886,0.000053036838,0.0000064535793,0.001828842],"genre_scores_gemma":[0.9980246,0.0007356497,0.00018897535,0.0005040794,0.000016586011,0.000032490654,0.000022009199,0.0000048764973,0.0004709433],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99692994,0.0017396408,0.000112822665,0.00014338357,0.00031914926,0.00075515074],"domain_scores_gemma":[0.99561936,0.002319684,0.0005667133,0.00008575491,0.00039460073,0.0010137869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002878697,0.0004120081,0.0006549577,0.00064048334,0.0060820663,0.0029009916,0.0010518358,0.0014392073,0.0025759474],"category_scores_gemma":[0.006578223,0.00039325622,0.0004531641,0.0008289614,0.005247255,0.0022215554,0.0034648837,0.0022272067,0.00017702427],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047986017,0.000040555522,0.0086342115,0.00021158598,0.000009647325,0.0017058613,0.9843822,0.000030779018,0.00045877814,0.0003709489,0.00062721537,0.0034802058],"study_design_scores_gemma":[0.0000039733595,0.00008919268,0.00440271,0.00008777547,0.000006389124,0.0009499788,0.99149466,0.00003786389,0.00008487174,0.000083964915,0.0027440735,0.0000145021295],"about_ca_topic_score_codex":0.020635158,"about_ca_topic_score_gemma":0.033574473,"teacher_disagreement_score":0.020635158,"about_ca_system_score_codex":0.0028969394,"about_ca_system_score_gemma":0.003997232,"threshold_uncertainty_score":0.04103011},"labels":[],"label_agreement":null},{"id":"W4407007511","doi":"10.1177/17562872251314809","title":"Current utility, instruments, and future directions for intra-renal pressure management during ureteroscopy: scoping review by global research in intra-renal pressure collaborative group initiative","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Kidney Stones and Urolithiasis Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Ureteroscopy; Observational study; Sepsis; Intensive care medicine; Percutaneous; Nephrology; Perioperative; Surgery; Internal medicine; Ureter","score_opus":0.02853690268868526,"score_gpt":0.4072811247420486,"score_spread":0.37874422205336333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407007511","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013752318,0.9985057,0.00018087636,0.00054716953,0.00013518259,0.0000847942,0.00009807048,0.000008439297,0.00030230512],"genre_scores_gemma":[0.0009213252,0.99789846,0.00054379087,0.00027397345,0.00005885377,0.00013429586,0.00008446242,0.000003517573,0.00008130313],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926549,0.0019885649,0.0032355723,0.00046724503,0.0014096263,0.00024408048],"domain_scores_gemma":[0.95635855,0.03165363,0.0059411605,0.0007058827,0.0049803494,0.0003604366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016452644,0.0016996145,0.005883827,0.02229411,0.0010035918,0.0052902615,0.002844404,0.0030923176,0.004692986],"category_scores_gemma":[0.041887663,0.0011026501,0.0069520366,0.020643588,0.0015517037,0.0048463796,0.002569856,0.0021651324,0.0009504478],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008703692,0.000030372945,0.0005352252,0.701408,0.0010313633,0.00013297364,0.0005521203,0.00019854555,0.00024427177,0.0015648982,0.006045603,0.28816956],"study_design_scores_gemma":[0.000022562383,0.00005539598,0.0011470648,0.9245031,0.005498984,0.00025082874,0.0004040717,0.00008869617,0.00013549766,0.000752186,0.06711098,0.00003066205],"about_ca_topic_score_codex":0.011189274,"about_ca_topic_score_gemma":0.017599031,"teacher_disagreement_score":0.02229411,"about_ca_system_score_codex":0.004027211,"about_ca_system_score_gemma":0.024667775,"threshold_uncertainty_score":0.08701092},"labels":[],"label_agreement":null},{"id":"W4407426178","doi":"10.1177/17562872251317918","title":"Do Bowel Disorders Affect Holmium Laser Enucleation of Prostate Outcomes? A Retrospective Cohort Study","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Enucleation; Anticholinergic; Urinary retention; Retrospective cohort study; Cohort; Irritable bowel syndrome; Prostate; Internal medicine; Urology; Surgery","score_opus":0.010963128118507547,"score_gpt":0.3565706283404328,"score_spread":0.34560750022192527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407426178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952962,0.0032742547,0.00011746683,0.00005136348,0.000015535483,0.000024749133,0.00092982326,0.000003907615,0.00028661283],"genre_scores_gemma":[0.997954,0.0010072216,0.0000954966,0.000037294725,0.00001846476,0.000025266683,0.00078826415,0.0000040068576,0.000069900336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983479,0.0003606634,0.0003722867,0.0004442834,0.00027075785,0.00020415257],"domain_scores_gemma":[0.99280643,0.0011695835,0.004735402,0.0004311275,0.0004883157,0.00036911684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017472975,0.00026774485,0.0005687231,0.0013695654,0.0004076596,0.00076910533,0.00061386876,0.00052750733,0.0016181583],"category_scores_gemma":[0.0060832165,0.0003699721,0.0012422404,0.0020791276,0.0003308784,0.00089285075,0.00054052245,0.00041610678,0.00024141432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010899681,0.000012002789,0.9985442,0.000048181966,0.00019457875,0.00011210199,0.00004611858,0.0000111010495,0.000054000007,0.000008206293,0.00006288034,0.00079768454],"study_design_scores_gemma":[0.00001037579,0.00014477174,0.9984799,0.00003830096,0.00012783056,0.00071628706,0.00019671799,0.000041137475,0.0000298511,0.000008885825,0.00020060327,0.000005331066],"about_ca_topic_score_codex":0.003577517,"about_ca_topic_score_gemma":0.0048715626,"teacher_disagreement_score":0.003577517,"about_ca_system_score_codex":0.00033417472,"about_ca_system_score_gemma":0.0005157126,"threshold_uncertainty_score":0.009240687},"labels":[],"label_agreement":null},{"id":"W4410463937","doi":"10.1177/17562872251338430","title":"Outcomes of holmium laser enucleation of the prostate in men with a history of prostatitis: a retrospective study","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Enucleation; Prostatitis; Prostate; Retrospective cohort study; Urology; Prostate cancer; Prostatic Diseases; Internal medicine; Surgery","score_opus":0.012454727238454437,"score_gpt":0.3156377188542556,"score_spread":0.3031829916158012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410463937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990089,0.0005706494,0.000059581496,0.000012644506,0.0000035159235,0.000010635989,0.00009498885,0.0000016845214,0.00023740772],"genre_scores_gemma":[0.999632,0.00014876088,0.000032378666,0.000017055183,0.000008598045,0.00000797593,0.000112132,0.0000010763275,0.00003998022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993374,0.00014363279,0.00010015182,0.00015357438,0.0001534564,0.000111762274],"domain_scores_gemma":[0.99729353,0.00060797326,0.0014753474,0.00016323003,0.00016340011,0.00029648494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067454594,0.00019808614,0.00039371292,0.0006977335,0.0005596357,0.00050857296,0.00031418263,0.00043572008,0.0012210709],"category_scores_gemma":[0.0020385212,0.0002864403,0.00054326456,0.00070653384,0.00039047838,0.0005422067,0.0004806588,0.00041456995,0.0001895245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012643682,0.00003354363,0.99817765,0.000014088276,0.000028026994,0.00037365014,0.000054727072,0.000020545054,0.00010048086,0.0000077871355,0.00003539648,0.0010277069],"study_design_scores_gemma":[0.000013015429,0.00045840052,0.99474806,0.00001723171,0.000039281047,0.003980565,0.00029021915,0.000083935294,0.000097829885,0.000013853465,0.0002510718,0.0000066033567],"about_ca_topic_score_codex":0.0011886406,"about_ca_topic_score_gemma":0.0016268912,"teacher_disagreement_score":0.0012210709,"about_ca_system_score_codex":0.00037176695,"about_ca_system_score_gemma":0.00034859346,"threshold_uncertainty_score":0.0040848255},"labels":[],"label_agreement":null}]}